Return to: Pediatrics : Medical School : Academic Health Center : myU : U of M Home

Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
Pediatrics Blood and Marrow Transplantation
Whats Inside
For Patients and Families

Research

Education

Faculty and Staff

News & Events

Contact Us

 

Peds BMT Home




University Pediatrics Foundation - Make a Gift

Viking Children's Fund

Children's Cancer Research Fund

Home > Department of Pediatrics > Blood and Marrow Transplantation > Faculty and Staff > Satkiran Grewal, M.D.

Printer-friendly version   Mail this page to a friend

Satkiran Grewal, M.D.


Dr. Grewal

Assistant Professor
Mayo Mail Code 477
420 Delaware St. SE
Minneapolis, MN  55455
Phone: (612) 625-9428
Fax: (612) 626-4595
grewa002@umn.edu


Dr. Grewal is an Assistant Professor of Pediatrics in the Division of Hematology-Oncology and Blood and Marrow Transplantation and attends on the Pediatric Blood and Marrow Transplantation (BMT) service.  Dr. Grewal’s clinical specialty includes the use of BMT to treat inherited genetic diseases, especially metabolic storage diseases.

He received his M.B.B.S. (1986) and M.D. (1991) degrees from the University of Delhi, Maulana Azad Medical College. He completed his Pediatric Residency at the State University of New York (SUNY) at Stony Brook, NY and received his M.D. degree in Pediatrics from SUNY in 1991.  He then completed a fellowship in pediatric oncology at Washington University School of Medicine and St. Louis Children, St. Louis,MO in 2000 and a fellowship in pediatric blood and marrow transplantation at the University of Minnesota in 2001. Dr. Grewal joined the University of Minnesota Faculty in 2002. He is board certified in Pediatric Hematology-Oncology.

Dr. Grewal's primary clinical research interests focus on the use of enzyme replacement therapy in conjunction with BMT to treat Hurler syndrome and the development of a risk assessment scale that can be assigned to each patient following a comprehensive evaluation prior to BMT to assess the patient’s level of risk for developing post-transplant complications.  

Selected Recent Publications:

SS Grewal, W Krivit, TE Defor, EG Shapiro, PJ Orchard, SL AbelLALockman, RS Ziegler, KE Dusenbery and C Peters.  Outcome of second hematopoietic cell transplantation in Hurler syndrome.  Bone Marrow Transplantation 2002; 29(6): 491-496.

Satkiran S Grewal, Juliet N Barker, Stella M Davies, and John E Wagner. 
Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?  Blood. 2003; 101:4233-4244.

Satkiran Grewal, Elsa Shapiro, Elizabeth Braunlin, LawrenceCharnas, William Krivit, Paul Orchard, and Charles Peters.  Continued Neurocognitive Development and Prevention of Cardiopulmonary Complications after Successful BMT for I-Cell Disease: a long-term follow-up report.  Bone Marrow Transplantation. 2003; 32(9):957-960.

Satkiran S Grewal, Jeffrey P Kahn, Margaret L MacMillan, Norma K C Ramsay,
and John E Wagner.  Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA genotypically-identical sibling selected using preimplantation genetic diagnosis. Blood First Edition Paper, prepublished online 
September 22, 2003; DOI 10.1182/blood-2003-02-0587.

Satkiran S Grewal, MD, Elsa G Shapiro PhD, William Krivit MD PhD, Lawrence Charnas MD, PhD, Lawrence A Lockman MD, Kathleen A Delaney BA, Stella M Davies MBBS PhD, David A Wenger PhD, Frank L Rimell MD, Susan Abel RN, Alfred C Grovas MD, Paul J Orchard MD, John E Wagner MD, Charles Peters MD 

Effective treatment of alpha-mannosidosis by allogeneic hematopoietic stem cell transplantation (in print, J. Pediatr.).

 


Feedback | Notice of Privacy Practices


 
The University of Minnesota is an equal opportunity educator and employer.